Relationship between blood-brain barrier changes and drug metabolism under high-altitude hypoxia: obstacle or opportunity for drug transport?

被引:3
|
作者
Liu, Guiqin [1 ]
Bai, Xue [1 ]
Yang, Jianxin [1 ]
Duan, Yabin [2 ]
Zhu, Junbo [1 ]
Xiangyang, Li [1 ,3 ,4 ,5 ]
机构
[1] Qinghai Univ, Res Ctr High Altitude Med, Med Coll, Xining, Peoples R China
[2] Qinghai Univ, Affiliated Hosp, Xining, Peoples R China
[3] Qinghai Univ, State Key Lab Plateau Ecol & Agr, Xining, Peoples R China
[4] Qinghai Univ, State Key Lab Plateau Ecol & Agr, 256 Ningda Rd, Xining 810016, Peoples R China
[5] Qinghai Univ, Res Ctr High Altitude Med, Med Coll, Xining, Peoples R China
基金
中国国家自然科学基金;
关键词
Blood-brain barrier; high-altitude hypoxia; drug transporters; drug-metabolizing enzymes; drug transport; CEREBRAL-ISCHEMIA; P-GLYCOPROTEIN; SHORT-TERM; EXPRESSION; PERMEABILITY; EXPOSURE; INJURY; INCREASE; DISEASE; PROTEIN;
D O I
10.1080/03602532.2023.2180028
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The blood-brain barrier is essential for maintaining the stability of the central nervous system and is also crucial for regulating drug metabolism, changes of blood-brain barrier's structure and function can influence how drugs are delivered to the brain. In high-altitude hypoxia, the central nervous system's function is drastically altered, which can cause disease and modify the metabolism of drugs in vivo. Changes in the structure and function of the blood-brain barrier and the transport of the drug across the blood-brain barrier under high-altitude hypoxia, are regulated by changes in brain microvascular endothelial cells, astrocytes, and pericytes, either regulated by drug metabolism factors such as drug transporters and drug-metabolizing enzymes. This article aims to review the effects of high-altitude hypoxia on the structure and function of the blood-brain barrier as well as the effects of changes in the blood-brain barrier on drug metabolism. We also hypothesized and explore the regulation and potential mechanisms of the blood-brain barrier and associated pathways, such as transcription factors, inflammatory factors, and nuclear receptors, in regulating drug transport under high-altitude hypoxia.
引用
收藏
页码:107 / 125
页数:19
相关论文
共 50 条
  • [41] An ex Vivo Model for Evaluating Blood-Brain Barrier Permeability, Efflux, and Drug Metabolism
    Hellman, Karin
    Nielsen, Peter Aadal
    Ek, Fredrik
    Olsson, Roger
    ACS CHEMICAL NEUROSCIENCE, 2016, 7 (05): : 668 - 680
  • [42] Stem cell-based blood-brain barrier model for drug transport studies
    Mantle, Jennifer
    Lee, Kelvin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [43] Effects of High-altitude Hypoxia on Drug Metabolism and Pharmacokinetics of Sedative-hypnotic Drugs and Regulatory Mechanism
    Tian, Lu
    Liu, Guiqin
    Han, Junjun
    Li, Xiangyang
    CURRENT DRUG METABOLISM, 2024, 25 (06) : 416 - 424
  • [44] Blood-brain barrier-associated efflux transporters: a significant but underappreciated obstacle to drug development in glioblastoma
    Mason, Warren P.
    NEURO-ONCOLOGY, 2015, 17 (09) : 1181 - 1182
  • [46] Prediction of drug transport through the blood-brain barrier in vivo:: A comparison between two in vitro cell models
    Lundquist, S
    Renftel, M
    Brillault, J
    Fenart, L
    Cecchelli, R
    Dehouck, MP
    PHARMACEUTICAL RESEARCH, 2002, 19 (07) : 976 - 981
  • [47] Correlation of vascular endothelial growth factor to permeability of blood-brain barrier and brain edema during high-altitude exposure
    Zhou, Qiquan
    Liu, Chang'e
    Wang, Jing
    Wang, Yunli
    Zhou, Bo
    NEURAL REGENERATION RESEARCH, 2009, 4 (10) : 775 - 779
  • [48] Inhibition of P-Glycoprotein: Rapid Assessment of Its Implication in Blood-Brain Barrier Integrity and Drug Transport to the Brain by an In Vitro Model of the Blood-Brain Barrier
    Laurence Fenart
    Valeric Buée-Scherrer
    Laurence Descamps
    Christian Duhem
    Marie-Gwenaëlle Poullain
    Roméo Cecchelli
    Marie-Pierre Dehouck
    Pharmaceutical Research, 1998, 15 : 993 - 1000
  • [49] Inhibition of P-glycoprotein:: Rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier
    Fenart, L
    Buée-Scherrer, V
    Descamps, L
    Duhem, C
    Poullain, MG
    Cecchelli, R
    Dehouck, MP
    PHARMACEUTICAL RESEARCH, 1998, 15 (07) : 993 - 1000
  • [50] Prediction of Drug Transport Through the Blood-Brain Barrier in Vivo: A Comparison Between Two in Vitro Cell Models
    Stefan Lundquist
    Mila Renftel
    Julien Brillault
    Laurence Fenart
    Roméo Cecchelli
    Marie-Pierre Dehouck
    Pharmaceutical Research, 2002, 19 : 976 - 981